RxSight (RXST) Amortization of Deferred Charges (2020 - 2023)

RxSight has reported Amortization of Deferred Charges for 4 years, with the latest figure at $4000.0 in Q3 2023.

• For the quarter ending Q3 2023, Amortization of Deferred Charges fell 97.2% year-over-year to $4000.0; the trailing twelve-month figure through Jun 2024 stood at $4000.0 (down 99.3% YoY), and the FY2023 full-year result was $287000.0, down 48.01% from the prior year.
• Amortization of Deferred Charges for Q3 2023 stood at $4000.0, down from $142000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $216000.0 in Q2 2021, with the low at -$201000.0 in Q3 2021.
• Historically, Amortization of Deferred Charges has averaged $77083.3 across 4 years, with a median of $132500.0 in 2022.
• Annual changes were most pronounced in 2021 — Amortization of Deferred Charges slumped 1535.71% — and 2022, when it surged 900.0%.
• RxSight's Amortization of Deferred Charges stood at $44000.0 in 2020, then tumbled by 556.82% to -$201000.0 in 2021, then surged by 171.64% to $144000.0 in 2022, then sank by 97.22% to $4000.0 in 2023.
• The last three Amortization of Deferred Charges figures came in at $4000.0 (Q3 2023), $142000.0 (Q2 2023), and $141000.0 (Q1 2023), per Business Quant data.